PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES Rok 2023 v přehledu – Sepse | 207 / Anest intenziv Med. 2023;34(5):204-207 / ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA www.aimjournal.cz LITERATURA 1. Cilloniz C, Ferrer M, Liapikou A, Garcia‑Vidal C, Gabarrus A, Ceccato A, et al. Acute respiratory distress syndrome in mechanically ventilated patients with community‑acquired pneumonia. Eur Respir J. 2018 Mar 29;51(3):1702215. doi: 10.1183/13993003.02215-2017. PMID: 29545274. 2. Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen‑Blad H, et al. Dexamethasone and length of hospital stay in patients with community ‑acquired pneumonia: a randomised, double‑blind, placebo‑controlled trial. Lancet. 2011 Jun 11;377(9782):2023-30. doi: 10.1016/S0140-6736(11)60607-7. Epub 2011 Jun 1. PMID: 21636122. 3. Snijders D, Graaff C de, Werf T van der, Boersma W. Effect of excluding ICU‑admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP. Eur Respir J. 2012;40(Suppl 56):P1734. http://erj. ersjournals.com/content/40/Suppl_56/P1734.abstract. 4. Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter‑Widmer I, et al. Adjunct prednisone therapy for patients with community‑acquired pneumonia: a multicentre, double ‑blind, randomised, placebo‑controlled trial. Lancet. 2015 Apr 18;385(9977):1511-8. doi: 10.1016/S0140-6736(14)62447-8. Epub 2015 Jan 19. PMID: 25608756. 5. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community ‑acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015. 88. PMID: 25688779. 6. Wittermans E, Vestjens SMT, Spoorenberg SMC, Blok WL, Grutters JC, Janssen R, et al; Santeon‑CAP Study Group; Members of the Santeon‑CAP Study Group. Adjunctive treatment with oral dexamethasone in non‑ICU patients hospitalised with community ‑acquired pneumonia: a randomised clinical trial. Eur Respir J. 2021 Aug 12;58(2):2002535. doi: 10.1183/13993003.02535-2020. PMID: 33446608. 7. Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, et al; dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7. PMID: 32043986. 8. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‑acquired pneumonia in adults. Clin Infect, DiS. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159. PMID: 17278083; PMCID: PMC7107997. 9. Meduri GU, Shih MC, Bridges L, Martin TJ, El‑Solh A, Seam N, et al; ESCAPe Study Group. Low‑dose methylprednisolone treatment in critically ill patients with severe community ‑acquired pneumonia. Intensive Care Med. 2022 Aug;48(8):1009-1023. doi: 10.1007/s00134022-06684-3. Epub 2022 May 13. PMID: 35723686; PMCID: PMC9208259.3 10. Coelho LM, Salluh JI, Soares M, Bozza FA, Verdeal JC, Castro‑Faria‑Neto HC, et al. Patterns of c‑reactive protein RATIO response in severe community‑acquired pneumonia: a cohort study. Crit Care. 2012 Dec 12;16(2):R53. doi: 10.1186/cc11291. PMID: 22449513; PMCID: PMC3681380. 11. Monedero P, Gea A, Castro P, Candela‑Toha AM, Hernández‑Sanz ML, Arruti E, et al; COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care. 2021 Jan 4;25(1):2. doi: 10.1186/s13054-020-03422-3. PMID: 33397463; PMCID: PMC7780210. 12. Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al; CRICS‑TriGGERSep Network. Hydrocortisone in Severe Community‑Acquired Pneumonia. N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21. PMID: 36942789. 13. Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of Corticosteroids on Mortality and Clinical Cure in Community‑Acquired Pneumonia: A Systematic Review, Meta‑analysis, and Meta‑regression of Randomized Control Trials. Chest. 2023 Mar;163(3):484-497. doi: 10.1016/j.chest.2022. 08. 2229. Epub 2022 Sep 7. PMID: 36087797. 14. Pitre T, Abdali D, Chaudhuri D, Pastores SM, Nei AM, Annane D, et al. Corticosteroids in Community‑Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose ‑Response Meta‑Analysis. J Gen Intern Med. 2023 Aug;38(11):2593-2606. doi: 10.1007/s11606023-08203-6. Epub 2023 Apr 19. PMID: 37076606; PMCID: PMC10115386. 15. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. PMID: 32678530; PMCID: PMC7383595. 16. Santacruz CA, Pereira AJ, Celis E, Vincent JL. Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review. Crit Care Med. 2019 Dec;47(12):1680-1691. doi: 10.1097/CCM.0000000000004000. PMID: 31567349. 17. Inzucchi SE, Siegel MD. Glucose control in the ICU – how tight is too tight? N Engl J Med. 2009 Mar 26;360(13):1346-9. doi: 10.1056/NEJMe0901507. Epub 2009 Mar 24. PMID: 19318385. 18. Umpierrez GE. Glucose Control in the ICU. N Engl J Med. 2023 Sep 28;389(13):1234-1237. doi: 10.1056/NEJMe2309442. PMID: 37754290. 19. Dubois J, Van Herpe T, van Hooijdonk RT, Wouters R, Coart D, Wouters P, et al. Software ‑guided versus nurse‑directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial. Crit Care. 2017 Aug 14;21(1):212. doi: 10.1186/ s13054-017-1799-6. PMID: 28806982; PMCID: PMC5557320. 20. NICE‑SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24. PMID: 19318384. 21. Klein Klouwenberg PM, Frencken JF, Kuipers S, Ong DS, Peelen LM, van Vught LA, et al; MARS Consortium *. Incidence, Predictors, and Outcomes of New‑Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study. Am J Respir Crit Care Med. 2017 Jan 15;195(2):205-211. doi: 10.1164/rccm.201603-0618OC. PMID: 27467907. 22. Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R, et al. Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Med. 2023 Sep 12. doi: 10.1007/s00134-023-07208-3. Epub ahead of print. PMID: 37698594. 23. McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta‑analysis. JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528. PMID: 29801010; PMCID: PMC6583502. 24. Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al; CLASSIC Trial Group. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med. 2022 Jun 30;386(26):2459-2470. doi: 10.1056/NEJMoa2202707. Epub 2022 Jun 17. PMID: 35709019. 25. Karvunidis T, Matejovic M. Rok 2022 v přehledu – Sepse. Anest. intenziv Med. 2022;33(5):256-259. doi:10.36290/aim.2022.040. 26. Kjær MN, Meyhoff TS, Sivapalan P, Granholm A, Hjortrup PB, Madsen MB, et al. Long ‑term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023 Jul;49(7):820-830. doi: 10.1007/s00134-023-07114-8. Epub 2023 Jun 18. PMID: 37330928; PMCID: PMC10354110.
RkJQdWJsaXNoZXIy NDA4Mjc=